Skip to main content
. 2019 Feb 1;11(2):59. doi: 10.3390/pharmaceutics11020059

Scheme 1.

Scheme 1

(a) Ugi reaction for the surface modification of PAMAM-NH2 dendrimer and (b) biotinylated chlorambucil-dendrimer conjugates (3a/b5a/b) [33].